Johansson Agot, Liu Lu, Holmgren Susanne, Burcher Elizabeth
Department of Zoophysiology, University of Göteborg, Box 463, SE-405 30, Sweden.
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jul;370(1):35-45. doi: 10.1007/s00210-004-0943-4. Epub 2004 Jul 2.
Two tachykinin peptides, bufokinin and Xenopus neurokinin A (X-NKA) were recently isolated from Xenopus laevis. In this study we investigated the tachykinin receptors in the Xenopus gastrointestinal tract. In functional studies using stomach circular muscle strips, all peptides had similar potencies (EC50 values 1-7 nM). The rank order of potency to contract the intestine was physalaemin (EC50 1 nM)> or =bufokinin (EC50 3 nM)>substance P (SP)> or =cod SP>NKA>>X-NKA (EC50 1,900 nM). No maximum response could be obtained for [Sar9,Met(O2)11]SP, eledoisin and kassinin. In stomach strips, the mammalian tachykinin receptor antagonists RP 67580 (NK1) and MEN 10376 (NK2) had agonistic effects but did not antagonize bufokinin or X-NKA. In intestinal strips, RP 67580 (1 microM) reduced the maximal response to X-NKA but not bufokinin, while MEN 10376 was ineffective. [125I]BH-bufokinin bound with high affinity to a single class of sites, of KD 213+/-35 (stomach) and 172+/-9.3 pM (intestine). Specific binding of [125I]BH-bufokinin was displaced by bufokinin> or =SP>NKA> or =eledoisin approximately kassinin>X-NKA, indicating binding to a tachykinin NK1-like receptor. Selective tachykinin receptor antagonists were weak or ineffective. Other iodinated tachykinins ([125I]NKA and [125I]BH-eledoisin) displayed biphasic competition profiles, with the majority of sites preferring bufokinin rather than X-NKA. In conclusion, there is evidence for two different tachykinin receptors in Xenopus gastrointestinal tract. Both receptors may exist in stomach, whereas the bufokinin-preferring NK1-like receptor predominates in longitudinal muscle of the small intestine. Antagonists appear to interact differently with amphibian receptors, compared with mammalian receptors.
最近从非洲爪蟾中分离出了两种速激肽肽类,即蟾蜍速激肽和非洲爪蟾神经激肽A(X-NKA)。在本研究中,我们对非洲爪蟾胃肠道中的速激肽受体进行了研究。在用胃环形肌条进行的功能研究中,所有肽类的效力相似(EC50值为1 - 7 nM)。收缩肠道的效力顺序为:雨蛙肽(EC50 1 nM)≥蟾蜍速激肽(EC50 3 nM)>P物质(SP)≥鳕鱼P物质>NKA>>X-NKA(EC50 1900 nM)。对于[Sar9,Met(O2)11]SP、蛙皮素和肛褶蛙肽,无法获得最大反应。在胃条中,哺乳动物速激肽受体拮抗剂RP 67580(NK1)和MEN 10376(NK2)具有激动作用,但不拮抗蟾蜍速激肽或X-NKA。在肠条中,RP 67580(1 μM)降低了对X-NKA的最大反应,但对蟾蜍速激肽无影响,而MEN 10376无效。[125I]BH-蟾蜍速激肽以高亲和力与一类单一的位点结合,胃中的KD为213±35,肠中的KD为172±9.3 pM。[125I]BH-蟾蜍速激肽的特异性结合被蟾蜍速激肽≥SP>NKA≥蛙皮素≈肛褶蛙肽>X-NKA取代,表明其与速激肽NK1样受体结合。选择性速激肽受体拮抗剂作用较弱或无效。其他碘化速激肽([125I]NKA和[125I]BH-蛙皮素)表现出双相竞争曲线,大多数位点更倾向于蟾蜍速激肽而非X-NKA。总之,有证据表明非洲爪蟾胃肠道中存在两种不同的速激肽受体。两种受体可能都存在于胃中,而在小肠纵肌中,更倾向于蟾蜍速激肽的NK1样受体占主导。与哺乳动物受体相比,拮抗剂与两栖动物受体的相互作用似乎有所不同。